Research

Cannabis Course_143
20121108_MEDPHOTO_110
Cannabis Course_75

News

Gerson Interview with WCAX Highlights Lifesaving New Blood Cancer Treatment

June 18, 2024 by Lucy Gardner Carson

(JUNE 18, 2024) James Gerson, M.D., assistant professor of medicine, spoke with WCAX-TV about a new treatment for blood cancer launched last year that appears to be saving lives.

Eric Bergeron, a patient who has received the treatment (left), with CAR T program leader James Gerson, M.D., assistant professor of medicine

(JUNE 18, 2024) James Gerson, M.D., assistant professor of medicine, spoke with WCAX-TV about a new treatment for blood cancer launched last year that appears to be saving lives.

The novel, highly effective form of cancer treatment is called CAR T-cell therapy, and the UVM Cancer Center (UVMCC) is the only health care institution in Vermont and northern New York where it is available. The CAR T program is led by Gerson, who came to UVM from the University of Pennsylvania, where CAR T-cell therapy was discovered and developed.

UVMCC officials say 12 patients have been treated and many of them are still free of cancer. Eric Bergeron, a patient who has received the treatment, joined Gerson in the WCAX interview.

Read the full story at the UVM Cancer Center webpage.

Read full story at WCAX-TV